The Wistar Institute's Paul M. Lieberman, Ph.D. and lab identified and tested a new method for targeting certain cancers ...
In multiple sclerosis (MS), antibodies to the common Epstein-Barr virus can accidentally attack a protein in the brain and ...
New research highlights a critical link between antibodies produced against Epstein-Barr virus (EBV) and the development of ...
New research shows that the combination of certain viral antibodies and genetic risk factors can be linked to a greatly ...
Scientists from Sweden’s Karolinska Institutet have uncovered new clues about how the Epstein-Barr virus (EBV) might ...
News-Medical.Net on MSN1d
Combination of Epstein-Barr virus antibodies and genes linked to increased risk of MSIn multiple sclerosis (MS), antibodies to the common Epstein-Barr virus can accidentally attack a protein in the brain and spinal cord. New research shows that the combination of certain viral ...
AZoLifeSciences on MSN10h
Genes, Immune Response to Virus Boost MS RiskIn multiple sclerosis (MS), antibodies to the common Epstein-Barr virus can accidentally attack a protein in the brain and spinal cord. New research ...
A small U.S. study explored whether immune markers seen in many long COVID sufferers are also present in people with ...
Scientific revolutions spur industrial revolutions, which in turn drive economic progress. Enhancing innovation capabilities, ...
Several studies have suggested that COVID-19 may increase a person’s risk of developing cancer or promote metastasis of existing cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback